Meta Biomed Co. Ltd (059210) — Cash Flow Reinvestment Rate
Meta Biomed Co. Ltd (059210) has a Cash Flow Reinvestment Rate of 18.28x as of September 2025, reinvesting ₩19.27 Billion (capex ₩4.44 Billion plus investments ₩14.83 Billion) from operating cash flow of ₩1.05 Billion. Explore Meta Biomed Co. Ltd (059210) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Meta Biomed Co. Ltd Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Meta Biomed Co. Ltd across 11 annual periods. Also explore total assets of Meta Biomed Co. Ltd for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Meta Biomed Co. Ltd (2011–2024)
Year-by-year capital reinvestment analysis for Meta Biomed Co. Ltd. For live market cap and broader valuation context, see market value of Meta Biomed Co. Ltd.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.41x | ₩54.47 Billion | ₩22.63 Billion | ₩11.10 Billion | ▲ +6.0% |
| 2023 | 2.27x | ₩23.20 Billion | ₩10.22 Billion | ₩11.49 Billion | ▼ -30.6% |
| 2022 | 3.27x | ₩29.98 Billion | ₩9.16 Billion | ₩15.41 Billion | ▲ +333.1% |
| 2021 | 0.76x | ₩8.42 Billion | ₩11.14 Billion | ₩2.07 Billion | ▼ -62.1% |
| 2020 | 1.99x | ₩9.69 Billion | ₩4.86 Billion | ₩2.23 Billion | ▼ -26.6% |
| 2019 | 2.72x | ₩7.78 Billion | ₩2.86 Billion | ₩7.56 Billion | ▲ +76.6% |
| 2016 | 1.54x | ₩7.74 Billion | ₩5.03 Billion | ₩6.13 Billion | ▼ -26.0% |
| 2015 | 2.08x | ₩10.25 Billion | ₩4.93 Billion | ₩7.79 Billion | ▲ +67.7% |
| 2013 | 1.24x | ₩4.60 Billion | ₩3.71 Billion | ₩4.60 Billion | ▼ -9.7% |
| 2012 | 1.37x | ₩5.26 Billion | ₩3.83 Billion | ₩5.26 Billion | ▼ -31.5% |
| 2011 | 2.00x | ₩8.22 Billion | ₩4.10 Billion | ₩8.22 Billion | — |